Active Government Funding Opportunities

ERDC seeks to modernize its High Performance Computing platform into a cloud-forward ecosystem using emerging technologies and modern architectures. The initiative aims to transform user workflows and infrastructure for a resilient, scalable, and secure solution meeting evolving government needs.

This DoD funding supports patient-centered research to improve lung cancer outcomes and survivorship experiences. Projects must include patient/survivor advocates and can pursue translational or clinical research, including pilot trials.

This DoD funding supports translational lung cancer research converting promising discoveries into clinical applications. Applicants can pursue advanced preclinical studies or pilot clinical trials addressing priority research areas.

Broad Agency Announcement for optical radiation bioeffects and safety research. Seeks novel solutions for understanding and mitigating effects of optical radiation on human performance and health.

Develop novel therapeutics and diagnostic tools to prevent, treat, or detect tick-borne diseases like Lyme disease. This program funds R&D to address a significant public health threat through innovative medical countermeasures.

Accelerate cancer treatment breakthroughs through clinical trials testing new drugs, devices, and emerging therapies. This award funds rapid-cycle trials from proof-of-concept to phase III, addressing the urgent need to translate promising cancer interventions into patient care.

DoD seeks innovative, high-risk cancer research concepts to advance treatment options and patient outcomes for Service Members and military beneficiaries. Preliminary data not required; creative thinking and untested ideas addressing unmet clinical needs are prioritized.

Mature cancer research with near-term clinical impact for military health systems. Supports studies including clinical trials addressing congressionally directed priorities in oncology.

Supports early-stage, high-risk lung cancer research with potential for breakthrough discoveries. Designed for conceptually innovative projects, including a dedicated track for new faculty investigators seeking transformative advances.

This DoD grant funds exploratory research into tuberous sclerosis complex treatments, welcoming high-risk, innovative concepts without requiring preliminary data. It supports early-stage hypothesis development to advance breakthrough therapeutic approaches.

This DoD program funds innovative research into tuberous sclerosis complex (TSC) to drive critical discoveries and improve patient care. It welcomes both established researchers and investigators new to the TSC field, with separate competitive tracks.

This DoD award supports clinical translational research to advance tuberous sclerosis complex diagnosis, prognosis, and treatments from promising preclinical findings toward real-world clinical application. Multi-PI teams can collaborate on moving TSC research closer to patient care.

The Army seeks research ideas to advance understanding and countermeasures for tick-borne diseases affecting military readiness. This program supports early-stage scientific investigations to develop novel prevention, diagnosis, or treatment solutions.

The Army seeks translational research advancing vision science and optical technologies for military applications. This opportunity funds development of novel vision-related capabilities to bridge fundamental research and field-deployable solutions.

This Army Medical Research Acquisition Activity award supports mentored clinical research in vision-related medical challenges. It aims to develop clinical solutions and advance vision care capabilities through structured mentorship and research training.

This DoD program funds clinical trials for multiple sclerosis treatments, from early-stage proof-of-concept to phase 2 studies. It supports testing of new drugs, biologics, devices, and emerging technologies to improve MS management.

Supports investigator-led spinal cord injury research across basic to translational science phases. Aims to advance SCI patient care, treatment outcomes, and quality of life through competitive grants.

This DoD funding supports clinical trials testing new spinal cord injury treatments with potential to significantly improve patient outcomes. The program welcomes early-career researchers and requires community partnership to ensure research relevance.

This DoD funding supports early-stage lupus research planning, pilot studies, and phase 0/1 clinical trials to generate preliminary data and demonstrate feasibility for future interventional studies. Awards must include patient advocates and address FY26 lupus research priorities.

This DoD funding supports clinical translation research to move spinal cord injury treatments from preliminary studies into larger clinical trials. It prioritizes removing barriers to clinical success and identifying effective diagnosis, treatment, and rehabilitation options.

This DoD funding accelerates spinal cord injury research from promising ideas to clinical applications through translational research. It supports early-career partnerships and requires community engagement to ensure real-world relevance.

DoD seeks innovative, high-risk lupus research addressing critical gaps in disease understanding and treatment. Early-career researchers can propose novel ideas with or without preliminary data, emphasizing breakthrough discoveries over incremental advances.

Support innovative, high-risk MS research concepts at early exploration stages through hypothesis development. This award funds groundbreaking studies that establish foundations for future scientific investigation, with no preliminary data required.

This DoD funding supports high-risk, high-reward lupus research with potential for major scientific impact. Researchers can pursue innovative approaches addressing priority focus areas without requiring preliminary data.

Support early-stage researchers investigating Multiple Sclerosis through independent, mentor-guided projects. This award develops the next generation of MS researchers by funding novel research questions and advancing scientific careers in neuroimmunology.